Intratumoral PH-762 for Cutaneous Carcinoma

Clinical trial NCT06014086 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06014086
Sponsor: Phio Pharmaceuticals Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Skin Malignant Melanoma of Skin Merkel Cell Carcinoma of Skin

Start date: 2023-11-07
Primary completion: 2025-12-29
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.